What is Organon's additional paid-in capital?

Organon (OGN) reported additional paid-in capital of $186M in Q1 2026.

How has Organon's additional paid-in capital changed year-over-year?

Organon's additional paid-in capital increased by 43.1% year-over-year, from $130M to $186M.

What does additional paid-in capital mean?

Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.

Organon OGN Additional Paid-In Capital

Additional Paid-In Capital at other companies

PfizerPFE

$94.77B+1.0%

The Cooper Companies, Inc.COO

$1.98B+2.1%

BiogenBIIB

$896.7M+42.4%

Amneal Pharmaceuticals, Inc.AMRX

$536.3M-1.7%

Envista Holdings CorporationNVST

$3.9B+1.2%

PBH

Prestige Consumer HealthcarePBH

$608.52M+2.5%

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's additional paid-in capital?: Organon (OGN) reported additional paid-in capital of $186M in Q1 2026.
How has Organon's additional paid-in capital changed year-over-year?: Organon's additional paid-in capital increased by 43.1% year-over-year, from $130M to $186M.
What does additional paid-in capital mean?: Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.